spacer
spacer

PDBsum entry 4wtf

Go to PDB code: 
protein dna_rna ligands metals links
Transferase/RNA PDB id
4wtf

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
536 a.a.
DNA/RNA
Ligands
5GS
Metals
_MN ×3
_CL
Waters ×81
PDB id:
4wtf
Name: Transferase/RNA
Title: Crystal structure of hcv ns5b genotype 2a jfh-1 isolate with s15g e86q e87q c223h v321i mutations and delta8 beta hairpin loop deletion in complex with gs-639475, mn2+ and symmetrical primer template 5'- caaaauuu
Structure: RNA primer template caaaauuu. Chain: t, p. Engineered: yes. RNA-directed RNA polymerase. Chain: a. Engineered: yes. Mutation: yes
Source: Synthetic: yes. Synthetic construct. Organism_taxid: 32630. Hepatitis c virus jfh-1. Organism_taxid: 356411. Variant: s15g c223h v321i delta8. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Resolution:
2.65Å     R-factor:   0.189     R-free:   0.234
Authors: T.E.Edwards,T.C.Appleby,M.E.Mcgrath
Key ref: T.C.Appleby et al. (2015). Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase. Science, 347, 771-775. PubMed id: 25678663 DOI: 10.1126/science.1259210
Date:
30-Oct-14     Release date:   11-Feb-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Q99IB8  (POLG_HCVJF) -  Genome polyprotein from Hepatitis C virus genotype 2a (isolate JFH-1)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3033 a.a.
536 a.a.*
Key:    Secondary structure
* PDB and UniProt seqs differ at 8 residue positions (black crosses)

DNA/RNA chains
  C-A-A-A-A-U-U-U 8 bases
  A-A-A-U-U-U 6 bases

 Enzyme reactions 
   Enzyme class 2: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
RNA(n)
+ ribonucleoside 5'-triphosphate
= RNA(n+1)
+ diphosphate
   Enzyme class 3: E.C.3.4.21.98  - hepacivirin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
   Enzyme class 4: E.C.3.4.22.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: E.C.3.6.1.15  - nucleoside-triphosphate phosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
ribonucleoside 5'-triphosphate
+ H2O
= ribonucleoside 5'-diphosphate
+ phosphate
+ H(+)
   Enzyme class 6: E.C.3.6.4.13  - Rna helicase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O = ADP + phosphate + H+
ATP
+ H2O
= ADP
+ phosphate
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1126/science.1259210 Science 347:771-775 (2015)
PubMed id: 25678663  
 
 
Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase.
T.C.Appleby, J.K.Perry, E.Murakami, O.Barauskas, J.Feng, A.Cho, D.Fox, D.R.Wetmore, M.E.McGrath, A.S.Ray, M.J.Sofia, S.Swaminathan, T.E.Edwards.
 
  ABSTRACT  
 
Nucleotide analog inhibitors have shown clinical success in the treatment of hepatitis C virus (HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-dependent RNA polymerase. Here we study the details of HCV RNA replication by determining crystal structures of stalled polymerase ternary complexes with enzymes, RNA templates, RNA primers, incoming nucleotides, and catalytic metal ions during both primed initiation and elongation of RNA synthesis. Our analysis revealed that highly conserved active-site residues in NS5B position the primer for in-line attack on the incoming nucleotide. A β loop and a C-terminal membrane-anchoring linker occlude the active-site cavity in the apo state, retract in the primed initiation assembly to enforce replication of the HCV genome from the 3' terminus, and vacate the active-site cavity during elongation. We investigated the incorporation of nucleotide analog inhibitors, including the clinically active metabolite formed by sofosbuvir, to elucidate key molecular interactions in the active site.
 

 

spacer

spacer